EBF Anticorpi
| Empty Table Header | Nome del prodotto | CATALOG # | Isotipo | Epitopo | Applicazione | Species | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|---|
EBF Anticorpo (C-8) | sc-137065 | mouse IgG2a κ | 1-300 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 14 | ||
EBF Anticorpo (D-8) | sc-137039 | mouse IgG2a κ | 1-300 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
EBF Anticorpo (H-6) | sc-398173 | mouse IgG1 κ | 376-405 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
EBF3 Anticorpo (N7Q) | sc-81999 | mouse IgG1 κ | 381-481 (h) | WB, IP, ELISA | m, r, h | new |
EBF CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
EBF1 Plasmide KO CRISPR/Cas9 (h) | sc-401258 | h | Gene Knockout | GFP | 0 | ||
EBF1 Plasmide HDR (h) | sc-401258-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EBF1 Plasmide Double Nickase (h) | sc-401258-NIC | h | Gene Knockout | Puromycin | 0 | ||
EBF1 Plasmide Double Nickase (h2) | sc-401258-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EBF3 Plasmide KO CRISPR/Cas9 (h) | sc-402181 | h | Gene Knockout | GFP | 0 | ||
EBF3 Plasmide HDR (h) | sc-402181-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
EBF3 Plasmide Double Nickase (h) | sc-402181-NIC | h | Gene Knockout | Puromycin | 0 | ||
EBF3 Plasmide Double Nickase (h2) | sc-402181-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
EBF4 Plasmide KO CRISPR/Cas9 (h) | sc-402438 | h | Gene Knockout | GFP | 0 |
EBF CRISPR Activation Products
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
EBF1 Plasmide di attivazione CRISPR (h) | sc-401258-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF1 Plasmide di attivazione CRISPR (h2) | sc-401258-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF2 Plasmide di attivazione CRISPR (h) | sc-402456-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF2 Plasmide di attivazione CRISPR (h2) | sc-402456-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF3 Plasmide di attivazione CRISPR (h) | sc-402181-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF4 Plasmide di attivazione CRISPR (h) | sc-402438-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
EBF4 Plasmide di attivazione CRISPR (h2) | sc-402438-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
EBF siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Nome del prodotto | CATALOG # | Species | Applicazione | MARCATORE | CITAZIONI | Valutazione |
|---|---|---|---|---|---|---|---|
EBF1 siRNA (h) | sc-106965 | h | Gene Silencing | N/A | 1 | ||
EBF1 Plasmide shRNA (h) | sc-106965-SH | h | Gene Silencing | Puromycin | 1 | ||
EBF1 shRNA (h) Particelle lentivirali | sc-106965-V | h | Gene Silencing | Puromycin | 1 | ||
EBF1 siRNA (m) | sc-143277 | m | Gene Silencing | N/A | 0 | ||
EBF2 siRNA (h) | sc-155997 | h | Gene Silencing | N/A | 0 | ||
EBF2 Plasmide shRNA (h) | sc-155997-SH | h | Gene Silencing | Puromycin | 0 | ||
EBF2 shRNA (h) Particelle lentivirali | sc-155997-V | h | Gene Silencing | Puromycin | 0 | ||
EBF3 siRNA (h) | sc-43743 | h | Gene Silencing | N/A | 0 | ||
EBF3 Plasmide shRNA (h) | sc-43743-SH | h | Gene Silencing | Puromycin | 0 | ||
EBF3 shRNA (h) Particelle lentivirali | sc-43743-V | h | Gene Silencing | Puromycin | 0 | ||
EBF3 siRNA (m) | sc-45938 | m | Gene Silencing | N/A | 0 | ||
EBF3 Plasmide shRNA (m) | sc-45938-SH | m | Gene Silencing | Puromycin | 0 | ||
EBF3 shRNA (m) Particelle lentivirali | sc-45938-V | m | Gene Silencing | Puromycin | 0 | ||
EBF4 siRNA (h) | sc-77217 | h | Gene Silencing | N/A | 0 | ||
EBF4 Plasmide shRNA (h) | sc-77217-SH | h | Gene Silencing | Puromycin | 0 | ||
EBF4 shRNA (h) Particelle lentivirali | sc-77217-V | h | Gene Silencing | Puromycin | 0 | ||
EBF4 siRNA (m) | sc-143279 | m | Gene Silencing | N/A | 0 |